Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Beckman Coulter expands flow cytometry portfolio

This article was originally published in Clinica

Executive Summary

Beckman Coulter Life Sciences has acquired the flow cytometry business of ReaMetrix India, a Bangalore-based life science technology company. ReaMetrix was among the first to bring to the market dry, room temperature-stable reagents for in vitro diagnostic use, according to Beckman Coulter. The products, which are CE-marked but not yet cleared by the US FDA, are used for routine clinical analyses, specifically HIV monitoring and clinical research, two key flow cytometry market segments. They help to “simplify the sample preparation process” and in turn increase productivity of cytometrists, and will enable to broaden Beckman’s existing flow cytometry offerings.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts